Expression of topoisomerase IIα in the G0/G1 cell cycle phase of fresh leukemic cells
- 30 November 2001
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 25 (11) , 961-966
- https://doi.org/10.1016/s0145-2126(01)00062-5
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Correlation between p53, c-erbB-2, and topoisomerase II? expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implicationsThe Journal of Pathology, 1999
- Five putative drug resistance parameters (MDR1/P‐glycoprotein, MDR‐associated protein, glutathione‐S‐transferase, bcl‐2 and topoisomerase IIα) in 57 newly diagnosed acute myeloid leukaemiasEuropean Journal of Haematology, 1997
- Differential expression of DNA topoisomerase II α and -β in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC4British Journal of Cancer, 1996
- Antitopoisomerase drug action and resistancePublished by Elsevier ,1996
- DNA TOPOISOMERASESAnnual Review of Biochemistry, 1996
- Topoisomerase II levels and drug sensitivity in adult acute myelogenous leukemiaBlood, 1994
- Altered gene expression in human leukemia K562 cells selected for resistance to etoposideBiochemical Pharmacology, 1993
- Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase IIBiochemistry, 1989
- DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGSAnnual Review of Biochemistry, 1989
- Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle.Proceedings of the National Academy of Sciences, 1988